البلد: إسرائيل
اللغة: الإنجليزية
المصدر: Ministry of Health
ENOXAPARIN SODIUM
TZAMAL BIO-PHARMA LTD
B01AB05
SOLUTION FOR INJECTION
ENOXAPARIN SODIUM 100 MG / 1 ML
S.C, I.V
Required
ROVI PHARMA INDUSTRIAL SERVICES S.A, SPAIN
ENOXAPARIN
Crusia is indicated in adults for:•Prophylaxis of venous thromboembolic disease in moderate and high risk surgical patients, in particular those undergoing orthopaedic or general surgery including cancer surgery.•Prophylaxis of venous thromboembolic disease in medical patients with an acute illness (such as acute heart failure, respiratory insufficiency, severe infections or rheumatic diseases) and reduced mobility at increased risk of venous thromboembolism.•Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), excluding PE ikely to require thrombolytic therapy or surgery. Prevention of thrombus formation in extra corporeal circulation during haemodialysis.•Acute coronary syndrome:-Treatment of unstable angina and Non ST-segment elevation myocardial infarction (NSTEMI), in combination with oral acetylsalicylic acid.-Treatment of acute ST-segment elevation myocardial infarction (STEMI) including patients to be managed medically or with subsequent percutaneous coronary intervention (PCI).
2019-11-05
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986 The medicine is dispensed with a doctor's prescription only Crusia Solution for injection in a pre-filled syringe with a safety system 20 mg/0.2 ml, 40 mg/0.4 ml, 60 mg/0.6 ml, 80 mg/0.8 ml, 100 mg/1.0 ml Crusia Forte Solution for injection in a pre-filled syringe with a safety system 120 mg/0.8 ml, 150 mg/1.0 ml Active ingredient and its quantity: Each syringe of Crusia respectively contains: Enoxaparin Sodium 20 mg, 40 mg, 60 mg, 80 mg or 100 mg Each syringe of Crusia Forte respectively contains: Enoxaparin Sodium 120 mg or 150 mg For a list of inactive ingredients, please see section 6. Read the entire leaflet carefully before using the medicine. Keep this leaflet, you may need to read it again. This leaflet contains concise information about the medicine. If you have any other questions, refer to the doctor or the pharmacist. This medicine has been prescribed for your treatment. Do not pass it on to others. It may harm them even if it seems to you that their medical condition is similar. If a side effect worsens or if a side effect that is not mentioned in this leaflet appears, refer to the doctor or pharmacist. Crusia/Crusia Forte is a biosimilar preparation. For additional information about biosimilar preparations refer to the Ministry of Health website: https://www.health.gov.il/UnitsOffice/HD/MTI/Drugs/Registration/Pages/Biosimilars.aspx Please note, every time you collect the medicine at the pharmacy, it is important that you make sure you get the same medicine your attending specialist doctor prescribed for you. If the medicine you received looks different from the one you usually receive, or the directions for use have been changed, immediately refer to the pharmacist in order to confirm that you have been supplied with the correct medicine. Any switch or change in the dosage of a medicine containing enoxaparin sodium must be conducted by the attending specialist doctor only. Please check that the trade name of th اقرأ الوثيقة كاملة
PHYSICIAN'S PRESCRIBING INFORMATION 1 NAME OF THE MEDICINAL PRODUCT CRUSIA CRUSIA FORTE 2 QUALITATIVE AND QUANTITATIVE COMPOSITION _ _ CRUSIA _2,000 IU (20 mg) /0.2 mL _ Each pre-filled syringe contains enoxaparin sodium 2,000 IU anti-Xa activity (equivalent to 20 mg) in 0.2 mL water for injections. _4,000 IU (40 mg) /0.4 mL _ Each pre-filled syringe contains enoxaparin sodium 4,000 IU anti-Xa activity (equivalent to 40 mg) in 0.4 mL water for injections. _ _ _6,000 IU (60 mg) /0.6 mL _ Each pre-filled syringe contains enoxaparin sodium 6,000 IU anti-Xa activity (equivalent to 60 mg) in 0.6 mL water for injections. _ _ _8,000 IU (80 mg) /0.8 mL _ Each pre-filled syringe contains enoxaparin sodium 8,000 IU anti-Xa activity (equivalent to 80 mg) in 0.8 mL water for injections. _ _ _ _ _10,000 IU (100 mg) /1 mL _ Each pre-filled syringe contains enoxaparin sodium 10,000 IU anti-Xa activity (equivalent to 100 mg) in 1 mL water for injections. _ _ CRUSIA FORTE _12,000 IU (120 mg) /0.8 mL _ Each pre-filled syringe contains enoxaparin sodium 12,000 IU anti-Xa activity (equivalent to 120 mg) in 0.8 mL water for injections. _ _ _ _ _15,000 IU (150 mg) /1 mL _ Each pre-filled syringe contains enoxaparin sodium 15,000 IU anti-Xa activity (equivalent to 150 mg) in 1 mL water for injections. _ _ For the full list of excipients, see section 6.1. Enoxaparin sodium is a biological substance obtained by alkaline depolymerization of heparin benzyl ester derived from porcine intestinal mucosa. 3 PHARMACEUTICAL FORM Solution for injection in pre-filled syringe. Clear, colourless to pale yellow solution. CRUSIA/CRUSIA FORTE is a biosimilar medicinal product that has been demonstrated to be similar in quality, safety and efficacy to the reference medicinal product Clexane. Please be aware of any differences in the indications between the biosimilar medicinal product and the reference medicinal product. The biosimilar is not to be switched with the reference medicinal product unless specifically stated otherwise. More detailed informat اقرأ الوثيقة كاملة